In Brief: HIMA staff changes
This article was originally published in The Gray Sheet
HIMA staff changes: Former Department of Commerce International Trade Specialist Paul Barry assumes position as director of global strategy and analysis at the Health Industry Manufacturers Association, effective Jan. 2. Barry replaces Terri Zavada, who left HIMA Dec. 5 to establish Zavada International, a consulting firm dealing with international medical device trade issues with an emphasis on Asia. Barry has worked extensively with HIMA in the past on device issues, particularly on matters related to reimbursement in Japan, in the context of the Pharmaceutical Products Market-Oriented Sector-Selective (MOSS) trade talks. Yet to be named is a replacement for HIMA Associate VP-Public Affairs Holly Glass, who left the trade association Sept. 15 to establish Glass Public Affairs, a device public relations firm. HIMA Manager of Government Affairs Jeanne Wilton also is leaving the association to enter consulting; a replacement has not yet been designated...
You may also be interested in...
Asking whether FDA’s decision to allow emergency use of two old anti-malarial drugs was ‘political’ misses the point. The issue already was political, and FDA’s action may well be the best way to keep some measure of federal control on supplies of a drug with important other uses.
Guidelines for health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.